Matinas BioPharma
MTNB
MTNB
50 hedge funds and large institutions have $21.5M invested in Matinas BioPharma in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
Holders
50
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.37M | |
| 2 | +$418K | |
| 3 | +$250K | |
| 4 |
Jane Street
New York
|
+$117K |
| 5 |
VF
Virtu Financial
New York
|
+$73K |
Top Sellers
| 1 | -$528K | |
| 2 | -$62.8K | |
| 3 | -$40K | |
| 4 |
JPMPWA
J.P. Morgan Private Wealth Advisors
San Francisco,
California
|
-$26K |
| 5 |
IWC
Integrated Wealth Concepts
Waltham,
Massachusetts
|
-$20K |